Effects of Transdermal Scopolamine on Occupational Performance

NCT00374478 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Motion Sickness

Interventions

DRUG: Scopolamine

Sponsor

Boston University

Collaborators

[object Object]